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Abstract
Background: Extraintestinal pathogenic E. coli are mostly responsible for a diverse spectrum of invasive human and animal
infections leading to the urinary tract infections. Bacterial lipopolysaccharides are responsible for their pathogenicity and
their interactions with host immune responses. In spite of several breakthroughs in the development of therapeutics to
combat urinary tract infections and related diseases, the emergence of multidrug-resistant bacterial strains is a serious
concern. Lipopolysaccharides are attractive targets for the development of long-term therapeutic agents to eradicate the
infections. Since the natural sources cannot provide the required amount of oligosaccharides, development of chemical
synthetic strategies for their synthesis is relevant to gain access to a reservoir of oligosaccharides and their close analogs.
Methodology: Two tetrasaccharide derivatives were synthesized from a single disaccharide intermediate. b-D-mannoside
moiety was prepared from b-D-glucoside moiety following oxidation–reduction methodology. A [2+2] stereoselective block
glycosylation strategy has been adopted for the preparation of tetrasaccharide derivative. a-D-Glucosamine moiety was
prepared from a-D-mannosidic moiety following triflate formation at C-2 and SN
2 substitution. A one-pot iterative
glycosylation exploiting the orthogonal property of thioglycoside was carried out during the synthesis of tetrasaccharide
analog.
Results: Synthesis of the tetrasaccharide motif (1) and its structural analog (2) corresponding to the lipopolysaccharide of
Escherichia coli O75 was successfully achieved in excellent yield. Most of the reactions are clean and high yielding. Both
compounds 1 and 2 were synthesized as their 4-methoxyphenyl glycoside, which can act as a temporary anomeric
protecting group for further use of these tetrasaccharides in the preparation of glycoconjugates.
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Introduction
Escherichia coli (E. coli) are opportunistic pathogen belong to the
Gram-negative Enterobacteriaceae. Pathogenic E. coli are the
major causative agents for a number of extra intestinal infections
in humans and animals [1]. One of the most frequently occurring
E. coli infections is urinary tract infections. Escherichia coli strains are
responsible for 60 to 80% of community acquired urinary tract
infections in children and adults [2,3]. Extra intestinal pathogenic
E. coli are mostly responsible for a diverse spectrum of invasive
human and animal infections leading to pyelonephritis in the
developing and developed countries [4,5,6]. The mechanism of
such kind of ascending urinary tract infections has been explained
based on the interactions between E. coli adhesion and their
uroepithelial receptor ligands [7]. The most of the urinary tract
infections found in human are caused by a small number of E. coli
O-serogroups e.g. O4, O6, O14, O22, O75 and O83 [8].
Furthermore, they have phenotypes that are epidemiologically
associated with cystitis and acute pyelonephritis in the normal
urinary tract [9,10]. In this context, a revised structure of the E. coli
O75 lipopolysaccharide has been reported by Erbing et. al. [11]
(Figure 1). Bacterial lipopolysaccharides play vital roles for their
pathogenicity and their interactions with host immune responses.
In spite of several breakthroughs in the development of
therapeutics to combat urinary tract infections and related
diseases, the emergence of multi drug resistant bacterial strains is
a serious concern. The epidemiological data for the urinary tract
infections caused by multi-drug resistant E. coli O75 and other
strains in the developed and developing countries have been well
documented [12–14]. Bacterial lipopolysaccharides and their
fragments have been used to prepare several glycoconjugate
derivatives towards the development of long term therapeutic
agents to eradicate the infections [15–17]. In order to establish a
clear understanding on the biological potential of the lipooligo-
saccharide of a particular strain and its glycoconjugates, it is
essential to carry out several biological experiments which require
pure oligosaccharide in large quantity. Since the natural sources
can not provide the required amount of the oligosaccharides,
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relevant to get access to a reservoir of oligosaccharides and their
close analogs. As a part of the ongoing studies on the synthesis of
oligosaccharides of bacterial origin for their use in the preparation
of glycoconjugate derivatives, concise chemical synthetic strategies
for the synthesis of tetrasaccharide repeating unit (1) (Figure 2)
corresponding to the lipopolysaccharide of Escherichia coli O75 and
its close tetrasaccharide analog (2) (Figure 3) are reported herein.
The difference between tetrasaccharides 1 and 2 is that the D-
glucosamine moiety is 1,2-trans linked in compound 1 whereas it is
1,2-cis linked in compound 2. Both tetrasaccharides 1 and 2 were
synthesized as their 4-methoxyphenyl (PMP) glycosides.
Results and Discussion
The synthesis of the tetrasaccharide 1 and its close structural
analog 2 as their 4-methoxyphenyl glycosides was achieved by
series of stereoselective glycosylations of a number of suitably
functionalized monosaccharide derivatives 4, 5 [18], 6, 7, 8 [19],
and 9 [20] prepared from the commercially available reducing
sugars using synthetic methodologies reported earlier. Since, the
preparation of b-linked D-mannose moiety from D-mannose and
a-D-glucosamine moiety from D-glucosamine are challenging
issues, these two moieties are successfully prepared using b-D-
glucosyl moiety and a-D-mannosyl moiety respectively as the
precursors after completion of the glycosylations with required
stereochemical outcome. The key features of this synthetic strategy
include, (a) use of a common disaccharide derivative 11 for the
preparation of both 1 and 2; (b) convenient conversion of b-D-
glucoside moiety to b-D-mannoside moiety using Dess-Martin
periodinane oxidation of C-2 followed by sodium borohydride
reduction of the keto- group; (c) [2+2] stereoselective block
glycosylation; (d) use of a-D-mannosidic moiety as a precursor for
a-D-glucosamine moiety; (e) triflate formation followed by SN
2
substitution by azido group at C-2 position of a-D-mannosidic
moiety; (f) high yield in most of the intermediate steps.
4-Methoxyphenyl 3-O-allyl-2,6-di-O-benzyl-a-D-galactopyrano-
side (4) was prepared from 4-methoxyphenyl 2,3,4,6-tetra-O-
acetyl-a-D-galactopyranoside (3) [21] using a series of reactions
involving (a) deacetylation using sodium methoxide; (b) 3,4-O-
isopropylidene ketal formation using 2,2-dimethoxypropane and p-
toluenesulfonic acid [22]; (c) benzylation using benzyl bromide
and sodium hydroxide [23]; (d) acidic hydrolysis of isopropylidene
ketal and (e) selective 3-O-allylation via stannylidene acetal
formation [24] in 70% overall yield (Scheme S1).
Stereo selective glycosylation of compound 4 with glucosyl
trichloroacetimidate derivative 5 [18] in the presence of trifluor-
omethane sulfonic acid (TfOH) [25] furnished 4-methoxyphenyl
(2-O-acetyl-3,4,6-tri-O-benzyl-b-D-glucopyranosyl)-(1R4)-3-O-al-
lyl-2,6-di-O-benzyl-a-D-galactopyranoside (10) in 72% yield. For-
mation of compound 10 was confirmed from its spectral analysis
[d 5.24 (d, J=3.5 Hz, H-1A), 4.61 (d, J=8.0 Hz, H-1B) in the
1H
NMR and d 101.8 (C-1B), 97.4 (C-1A) in the
13C NMR spectra].
The coupling constant value (J1,2=8.0 Hz) unambiguously
confirmed the b-linkage of the D-glucose moiety in compound
10. The D-glucopyranosyl moiety in compound 10 was converted
into a D-mannopyranosyl moiety by epimerization at C-2. For this
purpose, removal of acetyl group in compound 10 using sodium
methoxide and oxidation of the hydroxyl group using Dess-Martin
Periodinane [26] followed by reduction of the resulting keto group
using sodium borohydride [27] resulted in the b-D-mannopyr-
anosyl moiety, which was acetylated to give compound 11 in 76%
overall yield. The spectral analysis of compound 11 supported its
formation [d 5.19 (d, J=3.0 Hz, H-1A), 4.81 (br s, H-1B) in the
1H
NMR and d 99.1 (C-1B), 97.8 (C-1A) in the
13C NMR spectra].
The formation of b-D-mannosidic residue in compound 11 was
unambiguously confirmed from the NMR spectral data [d 4.81 (br
s, H-1B) and d 99.1 (C-1B) in the
1H NMR and
13C NMR spectra
respectively]. Since the presence of b-D-glucosidic moiety in
compound 10 was unambiguously confirmed from the NMR
spectra and the b-D-mannosidic moiety of the compound 11 was
prepared from the b-D-glucosidic moiety of compound 10 by
oxidation-reduction at the C-2 center without affecting the
stereochemistry at the glycosyl linkages, the glycosyl linkage of
the D-mannosidic moiety in compound 11 remained as b-linked
(1,2-cis). Compound 11 was treated with palladium chloride [28]
to remove allyl group to give compound 12 in 76% yield. In
another set of experiment, the O-acetyl group of compound 11
was transformed into benzyl group on treatment with benzyl
bromide in the presence of solid sodium hydroxide [23] to give
compound 13 in 90% yield, which was treated with palladium
chloride [28] to furnish compound 14 in 78% yield. Spectral
analysis of compound 14 supported its formation [d 5.46 (d,
J=3.2 Hz, H-1A), 4.77 (br s, H-1B)i n
1H NMR and d 101.8 (C-
1B), 96.8 (C-1A) in the
13C NMR spectra] (Scheme S2).
Stereoselective glycosylation of thioglycoside derivative 6 with
thioglycoside derivative 7 in the presence of a combination of N-
iodosuccinimide (NIS) and trifluoromethane sulfonic acid (TfOH)
Figure 1. Tetrasaccharide repeating unit corresponding to the
O-specific lipopolysaccharide of Escherichia coli O75.
doi:10.1371/journal.pone.0037291.g001
Figure 2. Structure of the tetrasaccharide repeating unit corresponding to the O-specific lipopolysaccharide of Escherichia coli O75.
doi:10.1371/journal.pone.0037291.g002
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77% yield exploiting the concept of ‘‘Relative reactivity values’’ of
thioglycosides discussed in the earlier report [31] (Scheme S3).
Using block synthetic strategy, stereoselective glycosylation of
disaccharide thioglycoside 15 with disaccharide acceptor 12 in the
presence of a combination of NIS and TfOH [29,30] furnished
tetrasaccharide derivative 16 in 72% yield. Spectral analysis of
compound 16 confirmed its formation [d 5.49 (s, PhCH), 5.43 (d,
J=8.0 Hz, H-1C), 4.90 (br s, H-1B), 4.66 (d, J=3.5 Hz, H-1A)i n
the
1H NMR and d 102.1 (PhCH), 99.5 (C-1C), 98.8 (C-1B), 97.3 (2
C, C-1A, C-1D) in the
13C NMR spectra]. Compound 16 was
subjected to a series of reactions involving (a) transformation of N-
phthalimido group to acetamido group by hydrazinolysis [31]
followed by N-acetylation; (b) removal of benzyl groups and
benzylidene acetal by exhaustive hydrogenolysis over pearlman’s
catalyst [32] and finally, (c) saponification using sodium methoxide
to furnish target tetrasaccharide 1 in 57% overall yield. Spectral
analysis of compound 1 unambiguously supported its formation [ d
5.30 (d, J=8.5 Hz, H-1C), 5.11 (d, J=3.5 Hz, H-1A), 4.80 (br s,
H-1D), 4.46 (br s, H-1B) in the
1H NMR and d 100.6 (C-1B), 100.2
(C-1D), 99.0 (C-1C), 98.4 (C-1A) in the
13C NMR spectra] (Scheme
S4).
In another synthetic strategy for the synthesis of compound 2,a
tetrasaccharide derivative 18 was prepared using a convergent
reaction protocol, which involves iodonium ion promoted iterative
stereoselective glycosylations in one-pot. Stereoselective conden-
sation of thioglycoside 8 and thioglycoside 9 in the first step of the
iterative glycosylation using NIS-TfOH [29,30] as promoter
furnished disaccharide thioglycoside derivative 17 following the
principle of ‘‘armed-disarmed’’ glycosylation concept [33,34].
Immediate reaction of the in situ generated disaccharide thioglyco-
side derivative 17 with the disaccharide acceptor 14 in the
presence of same activator present in the reaction pot led to the
formation of tetrasaccharide 18 in 71% overall yield together with
a minor quantity (,8%) of other isomeric product generated from
the first step of glycosylation, which was separated by column
chromatography. In the first step of the iterative glycosylation,
although both compound 8 and 9 are thioethyl glycosides,
presence of electron donating benzyl group at C-2 makes
compound 9 activated or armed to act as glycosyl donor, whereas
compound 8 acted as glycosyl acceptor because of the deactivation
due to the presence of electron withdrawing O-acetyl group at C-2.
In the second step, required 1,2-trans glycosylated product was
obtained due to the presence of O-acetyl group at C-2 of the in situ
formed disaccharide donor 17. The formation of tetrasaccharide
derivative 18 was unambiguously confirmed from its spectral
analysis [d 5.58 (s, PhCH), 5.41 (d, J=3.0 Hz, H-1A), 5.04 (br s,
H-1D), 5.02 (br s, H-1C), 4.63 (br s, 1 H, H-1B) in the
1H NMR
and d 101.5 (C-1B), 101.1 (PhCH), 97.6 (C-1A), 95.0 (C-1D), 94.0
(C-1C) in the
13C NMR spectra]. The stereochemistry of the
anomeric centers were further confirmed from the JC-1/H-1 values
in the proton coupled
13C NMR spectrum [Appearance JC-1/H-1:
172.0 Hz (a-Rhap), 174.0 (a-Manp), 168.0 Hz (a-Galp), 156.0 Hz
(b-Manp)] [35,36]. The D-mannose moiety in compound 18 was
converted to the D-glucosamine moiety following a series of
reactions involving (a) removal of O-acetyl group using sodium
methoxide; (b) treatment of the resulting hydroxyl group with
triflic anhydride to form triflate derivative; (c) treatment of the
triflate derivative with sodium azide to substitute triflate group
with azido group by SN
2 substitution [37]. Finally, removal of the
benzyl groups and transformation of the azido group to acetamido
group by hydrogenolysis followed by N-acetylation furnished
compound 2 in 51% overall yield. Spectral analysis of compound
2 unambiguously supported its formation [d 5.38 (d, J=3.5 Hz,
H-1A), 5.10 (d, J=1.5 Hz, H-1C), 4.90 (d, J=1.5 Hz, H-1D), 4.61
(br s, H-1B) in the
1H NMR and d 102.6 (C-1B), 100.7 (C-1A), 99.6
(C-1C), 98.0 (C-1D) in the
13C NMR spectra] (Scheme S5).
In summary, synthesis of the tetrasaccharide motif (1) and its
structural analog (2) corresponding to the O-specific lipopolysac-
charide of Escherichia coli O75 was successfully achieved in excellent
yield. A number of notable features are present in the synthetic
strategies, which include (a) preparation of b-D-mannosyl moiety
from b-D-glucosyl moiety using oxidation-stereoselective reduction
approach; (b) preparation of a-D-glucosaminyl moiety from a-D-
mannosyl moiety by SN
2 substitution of triflate with azido group;
(c) one-pot two iterative glycosylations; (d) [2+2] block glycosyl-
ation; (e) exploitation of orthogonal property of thioglycosides.
Most of the reactions are clean and high yielding.
Materials and Methods
General methods
All reactions were monitored by thin layer chromatography
over silica gel coated TLC plates. The spots on TLC were
visualized by warming ceric sulphate (2% Ce(SO4)2 in 2N H2SO4)
sprayed plates in hot plate. Silica gel 230–400 mesh was used for
column chromatography. 1D and 2D NMR spectra were recorded
on Bruker Avance 500 and 600 MHz spectrometer using CDCl3
and CD3OD as solvents and TMS as internal reference unless
stated otherwise. Chemical shift value is expressed in d ppm. ESI-
MS were recorded on a Micromass mass spectrometer. Elemen-
tary analysis was carried out on Carlo Erba analyzer. Optical
rotations were measured at 25 uC on a Jasco-P 2000 polarimeter.
Figure 3. Structure of the tetrasaccharide analog related to the repeating unit of the O-specific lipopolysaccharide of Escherichia coli
O75.
doi:10.1371/journal.pone.0037291.g003
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used in all reactions.
4-Methoxyphenyl 3-O-allyl-2,6-di-O-benzyl-a-D-
galactopyranoside (4)
A solution of compound 3 (5.0 g, 11.0 mmol) in 0.1 M
CH3ONa in CH3OH (50 mL) was stirred at room temperature
for 3 h and neutralized with Amberlite IR 120 (H
+) resin. The
reaction mixture was filtered and concentrated under reduced
pressure. To a solution of the crude product in anhydrous DMF
(15 mL) were added 2,2-dimethoxypropane (3 mL, 24.4 mmol)
and p-TsOH (250.0 mg) and reaction mixture was allowed to stir
at room temperature for 12 h. The reaction mixture was cooled to
0 uC and powdered NaOH (2.0 g, 50.0 mmol) was added to it
followed by benzyl bromide (2.6 mL, 21.9 mmol) and the reaction
was stirred at room temperature for 4 h. The reaction mixture was
diluted with water (150 mL) and the extracted with EtOAc
(26100 mL). The organic layer was washed with water, dried
(Na2SO4) and concentrated. A solution of the crude benzylated
product in 80% AcOH (100 mL) was stirred at 80 uC for 1.5 h.
The solvents were evaporated under reduced pressure and co-
evaporated with toluene and the crude product was passed
through a short pad of SiO2. To a solution of the dihydroxyl
compound in anhydrous CH3OH (150 mL) was added Bu2SnO
(4.0 g, 16.07 mmol) and the reaction was allowed to stir at 70 uC
for 3 h. The solvents were removed under reduced pressure and
the stannylidene acetal was dissolved in dry DMF (10 mL). To the
solution of the crude product were added allyl bromide (1.4 mL,
16.2 mmol) and Bu4NBr (500 mg) and the reaction mixture was
allowed to stir at 60 uC for 8 h. The reaction mixture was diluted
with water and extracted with EtOAc (26100 mL). The organic
layer was washed with 1 N HCl, satd. NaHCO3 and water in
succession, dried (Na2SO4) and concentrated. The crude product
was purified over SiO2 using hexane-EtOAc (4:1) as eluant to give
pure compound 4 (3.9 g, 70%). Yellow oil; [a]D
25+110.5 (c 1.2,
CHCl3); IR (neat): 3475, 2928, 1504, 1216, 1097, 1040, 756,
698 cm
21;
1H NMR (CDCl3, 500 MHz): d 7.34-7.23 (m, 10 H,
Ar-H), 7.03 (d, J=9.0 Hz, 2 H, Ar-H), 6.77 (d, J=9.0 Hz, 2 H,
Ar-H), 6.00-5.93 (m, 1 H, CH=CH 2), 5.35-5.31 (m, 1 H,
CH=CH2), 5.33 (d, J=3.0 Hz, 1 H, H-1), 5.21-5.19 (m, 1 H,
CH=CH2), 4.80 (d, J=12.0 Hz, 1 H, PhCH2), 4.67 (d,
J=12.0 Hz, 1 H, PhCH2), 4.49 (s, 2 H, PhCH2), 4.29-4.25 (m,
2 H, H-5, O-CH2-), 4.15-4.12 (m, 2 H, H-4, O-CH2), 3.94-3.93
(m, 2 H, H-6ab), 3.77 (dd, J=10.0, 5.4 Hz, 1 H, H-2), 3.73 (s, 3 H,
OCH3), 3.66 (dd, J=10.0, 6.1 Hz, 1 H, H-3); ESI-MS: 529.2
[M+Na]
+; Anal. Calcd. for C30H34O7 (506.23): C, 71.13; H,
6.76%; found: 70.90; H, 7.00%.
4-Methoxyphenyl (2-O-acetyl-3,4,6-tri-O-benzyl-b-D-
glucopyranosyl)-(1R4)-3-O-allyl-2,6-di-O-benzyl-a-D-
galactopyranoside (10)
A solution of compound 4 (2.0 g, 3.95 mmol) and compound 5
(3.0 g, 4.71 mmol) in anhydrous CH2Cl2 (25 mL) was cooled to
225uC. To the cooled reaction mixture was added TfOH
(100 mL) and the reaction mixture was allowed to stir at same
temperature for 1 h. The reaction mixture was diluted with
CH2Cl2 (150 mL) and successively washed with satd. NaHCO3
and water, dried (Na2SO4) and concentrated under reduced
pressure. The crude product was purified over SiO2 using hexane-
EtOAc (4:1) as eluant to give pure compound 10 (2.8 g, 72%).
Colorless oil; [a]D
25+38.8 (c 1.2, CHCl3); IR (neat): 2823, 2260,
1542, 1344, 1152, 1213, 1104, 1070, 737, 567 cm
21;
1H NMR
(CDCl3, 500 MHz): d 7.28-7.10 (m, 25 H, Ar-H), 6.95 (d,
J=9.0 Hz, 2 H, Ar-H), 6.67 (d, J=9.0 Hz, 2 H, Ar-H), 5.91-5.80
(m, 1 H, CH=CH 2), 5.32-5.28 (m, 1 H, CH=CH2), 5.24 (d,
J=3.5 Hz, 1 H, H-1A), 5.11-5.08 (m, 1 H, CH=CH2), 4.94 (t,
J=9.5 Hz each, 1 H, H-2B), 4.74-4.63 (4 d, J=11.8 Hz each, 4
H, PhCH2), 4.61 (d, J=8.0 Hz, 1 H, H-1B), 4.56 (d, J=11.5 Hz,
1 H, PhCH2), 4.51 (d, J=11.5 Hz, 1 H, PhCH2), 4.45 (d,
J=12.0 Hz, 1 H, PhCH2), 4.38 (d, J=12.0 Hz, 1 H, PhCH2),
4.35 (d, J=12.0 Hz, 1 H, PhCH2), 4.33 (d, J=12.0 Hz, 1 H,
PhCH2), 4.27-4.10 (m, 2 H, O-CH2), 4.08-4.06 (m, 2 H, H-4A,H -
5A), 3.84 (dd, J=10.0, 2.5 Hz, 1 H, H-2A), 3.80 (dd, J=10.0,
3.5 Hz, 1 H, H-3A), 3.77-3.74 (m, 1 H, H-6aB), 3.68 (dd, J=9.5,
3.5 Hz, 1 H, H-3B), 3.67 (s, 3 H, OCH3), 3.65-3.56 (m, 4 H, H-4B,
H-6bB, H-6abA), 3.39-3.37 (m, 1 H, H-5B), 1.92 (s, 3 H, OCH3);
13C NMR (CDCl3, 125 MHz): d 169.8 (COCH3), 155.1-114.4
(Ar-C, CH=CH2), 101.8 (C-1B), 97.4 (C-1A), 83.0 (C-3B), 77.8 (C-
4B), 77.6 (C-5B), 76.7 (C-4A), 75.3 (C-2A), 75.1 (PhCH2), 75.0
(PhCH2), 74.8 (C-3A), 73.8 (C-2B), 73.5 (PhCH2), 73.4 (PhCH2),
73.0 (PhCH2), 71.9 (O-CH2), 70.2 (C-5B), 71.1 (C-6B), 69.0 (C-6A),
55.6 (OCH3), 21.2 (COCH3); ESI-MS: 1003.4 [M+Na]
+; Anal.
Calcd. for C59H64O13 (980.43): C, 72.23; H, 6.57%; found: 72.00;
H, 6.85%.
4-Methoxyphenyl (2-O-acetyl-3,4,6-tri-O-benzyl-b-D-
mannopyranosyl)-(1R4)-3-O-allyl-2,6-di-O-benzyl-a-D-
galactopyranoside (11)
A solution of compound 10 (2.5 g, 2.55 mmol) in 0.1 M
CH3ONa in CH3OH (25 mL) was stirred at room temperature for
2 h and neutralized with Amberlite IR 120 (H
+) resin. The
reaction mixture was filtered and concentrated. To a solution of
the deacetylated product in anhydrous CH2Cl2 (15 mL) was
added Dess-Martin Periodinane (2.0 g, 4.72 mmol) and the
reaction mixture was allowed to stir at room temperature for
1 h. The reaction mixture was diluted with CH2Cl2 (100 mL) and
the organic layer was successively washed with 5% Na2S2O3, satd.
NaHCO3 and water, dried (Na2SO4) and concentrated under
reduced pressure. To a solution of the crude keto product in
CH3OH (50 mL) was added NaBH4 (1.5 g, 39.65 mmol) and the
reaction mixture was allowed to stir at room temperature for 12 h.
The solvents were removed under reduced pressure and the crude
mass was dissolved in CH2Cl2 (100 mL). The organic layer was
successively washed with 1 N HCl, satd. NaHCO3 and water,
dried (Na2SO4) and evaporated to dryness. A solution of the crude
epimerized product in acetic anhydride-pyridine (10 mL, 1:1 v/v)
was kept at room temperature for 2 h. The solvents were removed
under reduced pressure and the crude product was purified over
SiO2 using hexane-EtOAc (5:1) as eluant to give pure compound
11 (1.9 g, 76%). Yellow oil; [a]D
25+27.6 (c 1.2, CHCl3); IR (neat):
2818, 2220, 1549, 1365, 1159, 1235, 1100, 739 cm
21;
1H NMR
(CDCl3, 125 MHz): d 7.33-7.11 (m, 25 H, Ar-H), 6.94 (d,
J=9.0 Hz, 2 H, Ar-H), 6.66 (d, J=9.0 Hz, 2 H, Ar-H), 5.84-5.78
(m, 1 H, CH=CH 2), 5.72 (d, J=2.5 Hz, 1 H, H-2B), 5.23-5.20
(m, 1 H, CH=CH2), 5.19 (d, J=3.0 Hz, 1 H, H-1A), 5.05-5.03
(m, 1 H, CH=CH2), 4.81 (br s, 1 H, H-1B), 4.78-4.31 (10 d,
J=11.8 Hz each, 10 H, PhCH2), 4.26-4.23 (m, 1 H, O-CH2), 4.19
(br s, 1 H, H-4A), 4.10-4.06 (m, 2 H, H-5A, O-CH2), 3.93 (dd,
J=10.0, 3.5 Hz, 1 H, H-2A), 3.88 (dd, J=10.0, 2.5 Hz, 1 H, H-
3A), 3.71-3.63 (m, 4 H, H 4B, H-6abA, H-6aB), 3.64 (s, 3 H, OCH3),
3.58-3.53 (m, 2 H, H-3B, H-6bB), 3.37-3.34 (m, 1 H, H-5B), 2.09 (s,
3 H, COCH3);
13C NMR (CDCl3, 125 MHz): d 170.6 (COCH3),
155.1-114.4 (Ar-C, CH=CH2), 99.1 (C-1B), 97.8 (C-1A), 80.4 (C-
3B), 77.9 (C-3A), 76.4 (C-2A), 75.6 (C-5B), 75.2 (PhCH2), 74.4 (C-
4B), 74.2 (C-4A), 73.7 (PhCH2), 73.5 (PhCH2), 73.0 (PhCH2), 71.9
(PhCH2), 71.4 (PhCH2), 70.0 (C-5A), 69.9 (C-6B), 69.4 (C-6A), 68.1
(C-2B), 55.6 (OCH3), 21.1 (COCH3); ESI-MS: 1003.4 [M+Na]
+;
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4-Methoxyphenyl (2-O-acetyl-3,4,6-tri-O-benzyl-b-D-
mannopyranosyl)-(1R4)-2,6-di-O-benzyl-a-D-
galactopyranoside (12)
To a solution of compound 11 (900.0 mg, 0.92 mmol) in
anhydrous CH3OH (5 mL) was added PdCl2 (100.0 mg,
0.56 mmol) and the reaction mixture was allowed to stir at room
temperature for 1 h. The solvents were removed under reduced
pressure and the crude product was purified over SiO2 using
hexane-EtOAc (4:1) to give pure compound 12 (660.0 mg, 76%).
Yellow oil; [a]D
25+40 (c 1.2, CHCl3); IR (neat): 2834, 2297, 1534,
1371, 1156, 1218, 1080, 736 cm
21;
1H NMR (CDCl3, 500 MHz):
d 7.35-7.0 (m, 25 H, Ar-H), 6.91 (d, J=9.0 Hz, 2 H, Ar-H), 6.67
(d, J=9.0 Hz, 2 H, Ar-H), 5.62 (d, J=3.0 Hz, 1 H, H-2B), 5.21
(d, J=3.5 Hz, 1 H, H-1A), 4.78 (d, J=10.5 Hz, 1 H, PhCH2),
4.69 (br s, 1 H, H-1B), 4.67-4.61 (3 d, J=11.0 Hz each, 3 H,
PhCH2), 4.50-4.23 (6 d, J=11.0 Hz each, 6 H, PhCH2), 4.13-4.11
(m, 2 H, H-4A, H-5A), 4.09-4.06 (m, 1 H, H-6aA), 3.76-3.68 (m, 4
H, H-2A, H-4B, H-6aB, H-6bA), 3.67 (s, 3 H, OCH3), 3.65-3.61 (m,
1 H, H-3B), 3.59 (dd, J=10.0, 2.6 Hz, 1 H, H-3A), 3.54-3.51 (m, 1
H, H-6bB), 3.34-3.31 (m, 1 H, H-5B), 2.10 (s, 3 H, COCH3);
13C
NMR (CDCl3, 125 MHz): d 171.5 (COCH3), 155.1-114.5 (Ar-C),
100.5 (C-1B), 96.9 (C-1A), 80.1 (C-3B), 78.5 (C-3A), 76.6 (C-2A),
75.5 (C-5B), 75.2 (PhCH2), 74.3 (C-4B), 73.5 (C-4A), 73.0 (PhCH2),
72.8 (PhCH2), 71.5 (PhCH2), 69.8 (PhCH2), 69.5 (C-5A), 69.4 (C-
6B), 69.3 (C-6A), 68.7 (C-2B), 55.6 (OCH3), 21.3 (COCH3); ESI-
MS: 963.4 [M+Na]
+; Anal. Calcd. for C56H60O13 (940.40): C,
71.47; H, 6.43%; found: 71.26; H, 6.60%.
4-Methoxyphenyl (2,3,4,6-tetra-O-benzyl-b-D-
mannopyranosyl)-(1R4)-3-O-allyl-2,6-di-O-benzyl-a-D-
galactopyranoside (13)
To a solution of compound 11 (900.0 mg, 0.92 mmol) in THF
(5 mL) were added powdered NaOH (0.2 g, 5.0 mmol), benzyl
bromide (250 mL, 2.10 mmol) and Bu4NBr (25.0 mg) and reaction
mixture was allowed to stir at room temperature for 3 h. The
reaction mixture was diluted with CH2Cl2 (50 mL) and the
organic layer was washed with water, dried (Na2SO4) and
concentrated under reduced pressure. The crude product was
purified over SiO2 using hexane-EtOAc (7:1) as eluant to give pure
compound 13 (850.0 mg, 90%). Yellow oil; [a]D
25+20 (c 1.2,
CHCl3); IR (neat): 3443, 2923, 2860, 1508, 1454, 1362, 1213,
1114, 1070, 1027, 737, 697 cm
21;
1H NMR (CDCl3, 500 MHz):
d.7.55-7.14 (m, 30 H, Ar-H), 7.10 (d, J=9.0 Hz, 2 H, Ar-H), 6.75
(d, J=9.0 Hz, 2 H, Ar-H), 5.90-5.84 (m, 1 H, CH=CH 2), 5.40 (d,
J=3.0 Hz, 1 H, H-1A), 5.25-5.09 (m, 2 H, CH=CH 2), 4.93 (d,
J=12.0 Hz, 1 H, PhCH2), 4.89 (d, J=12.0 Hz, 1 H, PhCH2),
4.79 (d, J=12.0 Hz, 1 H, PhCH2), 4.76 (br s, 1 H, H-1B), 4.74 (d,
J=12.0 Hz, 1 H, PhCH2), 4.68 (d, J=12.0 Hz, 1 H, PhCH2),
4.61 (d, J=12.0 Hz, 1 H, PhCH2), 4.54 (d, J=12.0 Hz, 1 H,
PhCH2), 4.52 (d, J=12.0 Hz, 1 H, PhCH2), 4.48 (d, J=12.0 Hz,
1 H, PhCH2), 4.39 (br s, 2 H, PhCH2), 4.30-4.28 (m, 1 H, OCH2-),
4.27 (br s, 1 H, H-4A), 4.25-4.23 (m, 1 H, H-5A), 4.15-4.12 (m, 1
H, OCH2-), 4.01 (d, J=2.4 Hz, 1 H, H-2B), 3.97 (dd, J=10.2,
3.0 Hz, 1 H, H-3B), 3.93-3.88 (m, 2 H, H-2A, H-4B), 3.85 (dd,
J=10.8, 4.2 Hz, 1 H, H-6aB), 3.79-3.75 (m, 3 H, H-6bB, H-6abA),
3.73 (s, 3 H, OCH3), 3.51 (dd, J=9.6, 3.0 Hz, 1 H, H-3B), 3.42-
3.40 (m, 1 H, H-5B);
13C NMR (CDCl3, 125 MHz): d 155.6-114.4
(Ar-C, -CH=CH2), 101.6 (C-1B), 97.8 (C-1A), 82.5 (C-3B), 77.9 (C-
3A), 76.0 (C-2A), 75.9 (C-5B), 75.2 (PhCH2), 74.8 (C-4B), 73.9
(PhCH2), 73.8 (C-2B), 73.7 (C-4A), 73.4 (PhCH2), 73.1 (PhCH2),
73.0 (PhCH2), 71.7 (OCH2-), 71.4 (PhCH2), 70.4 (C-6B), 70.3 (C-
4A), 69.7 (C-6A), 55.5 (OCH3); ESI-MS: 1051.4 [M+Na]
+; Anal.
Calcd. for C64H68O12 (1028.47): C, 74.69; H, 6.66%; found:
74.90; H, 6.90%.
4-Methoxyphenyl (2,3,4,6-tetra-O-benzyl-b-D-
mannopyranosyl)-(1R4)-2,6-di-O-benzyl-a-D-
galactopyranoside (14)
To a solution of compound 13 (800.0 mg, 0.78 mmol) in
anhydrous CH3OH (5 mL) was added PdCl2 (90.0 mg,
0.51 mmol) and the reaction mixture was allowed to stir at room
temperature for 1 h. The solvents were removed under reduced
pressure and crude product was purified over SiO2 using hexane-
EtOAc (4:1) to give pure compound 14 (600.0 mg, 78%). White
solid; m.p. 132–133 uC (EtOH); [a]D
25+38 (c 1.2, CHCl3); IR
(KBr): 3440, 2936, 2854, 1512, 1466, 1345, 1209, 1121, 1078,
1037, 697 cm
21;
1H NMR (CDCl3, 500 MHz): d 7.47-7.20 (m, 30
H, Ar-H), 7.08 (d, J=9.0 Hz, 2 H, Ar-H), 6.77 (d, J=9.0 Hz, 2
H, Ar-H), 5.46 (d, J=3.2 Hz, 1 H, H-1A), 4.91-4.85 (3 d,
J=12.0 Hz each, 3 H, PhCH2), 4.77 (br s, 1 H, H-1B), 4.69 (d,
J=11.5 Hz, 1 H, PhCH2), 4.62-4.52 (m, 5 H, PhCH2), 4.47 (d,
J=11.5 Hz, 1 H, PhCH2), 4.43 (br s, 2 H, PhCH2), 4.25-4.22 (m,
2 H, H-3A, H-5A), 4.21 (br s, 1 H, H-4A), 3.97 (d, J=2.6 Hz, 1 H,
H-2B), 3.93-3.74 (m, 6 H, H-2A, H-4B, H-6abA, H-6abB), 3.73 (s, 3
H, OCH3), 3.54 (dd, J=9.2, 2.7 Hz, 1 H, H-3B), 3.48-3.46 (m, 1
H, H-5B);
13C NMR (CDCl3, 125 MHz): d 155.3-114.6 (Ar-C),
101.8 (C-1B), 96.8 (C-1A), 82.6 (C-3B), 75.8 (C-5B), 75.3 (C-2A),
75.0 (PhCH2), 74.9 (PhCH2), 74.0 (C-4B), 73.7 (C-3A), 73.5
(PhCH2), 73.0 (PhCH2), 72.5 (C-2B), 71.7 (PhCH2), 70.7 (C-4A),
70.5 (C-5A), 69.8 (C-6B), 69.7 (C-6A), 55.6 (OCH3); ESI-MS:
1011.4 [M+Na]
+; Anal. Calcd. for C61H64O12 (988.44): C, 74.07;
H, 6.52%; found: 74.25; H, 6.75%.
4-Methoxyphenyl (2,3,4-tri-O-acetyl-a-L-
rhamnopyranosyl)-(1R3)-(4,6-O-benzylidene-2-deoxy-2-
N-phthalimido-b-D-glucopyranosyl)-(1R3)-[2-O-acetyl-
3,4,6-tri-O-benzyl-b-D-mannopyranosyl-(1R4)]-2,6-di-O-
benzyl-a-D-galactopyranoside (16)
To a solution of compound 12 (600.0 mg, 0.64 mmol) and
compound 15 (550.0 mg, 0.77 mmol) in anhydrous CH2Cl2
(10 mL) was added MS 4 A ˚ (1.5 g) and the reaction mixture
was stirred under argon at room temperature for 30 min. The
reaction mixture was cooled to 230 uC and NIS (210.0 mg,
0.93 mmol) and TfOH (2 mL) were added to it. After stirring at
same temperature for 1 h the reaction mixture was filtered
through a CeliteH bed and washed with CH2Cl2 (50 mL). The
organic layer was successively washed with 5% Na2S2O3, satd.
NaHCO3 and water, dried (Na2SO4) and concentrated under
reduced pressure. The crude product was purified over SiO2 using
hexane-EtOAc (4:1) as eluant to give pure compound 16 (730 mg,
72%). White solid; m.p. 98–100 uC (EtOH); [a]D
25+10 (c 1.2,
CHCl3); IR (KBr): 2929, 1745, 1454, 1373, 1233, 1100, 1069,
754, 698 cm
21;
1H NMR (CDCl3, 500 MHz): d 7.76-6.99 (m, 34
H, Ar-H), 6.72 (d, J=9.0 Hz, 2 H, Ar-H), 6.55 (d, J=9.0 Hz, 2
H, Ar-H), 5.72-5.71 (m, 1 H, H-2B), 5.49 (s, 1 H, PhCH), 5.43 (d,
J=8.0 Hz, 1 H, H-1C), 5.15 (dd, J=10.0, 3.5 Hz, 1 H, H-3D),
5.03 (d, J=11.0 Hz, 1 H, PhCH2), 4.90 (br s, 1 H, H-1B), 4.86-
4.83 (m, 2 H, PhCH2), 4.80 (t, J=9.5 Hz each, 1 H, H-3C), 4.75
(t, J=10.0 Hz each, 1 H, H-4D), 4.66 (d, J=3.5 Hz, 1 H, H-1A),
4.64-4.63 (m, 1 H, H-2D), 4.53-4.50 (2 d, J=11.0 Hz each, 2 H,
PhCH2), 4.48 (br s, 1 H, H-1D), 4.40 (d, J=11.0 Hz, 1 H,
PhCH2), 4.32 (dd, J=10.5, 2.0 Hz, 1 H, H-6aC), 4.28-4.21 (2 d,
J=12.0 Hz each, 2 H, PhCH2), 4.20-4.15 (m, 3 H, H-2C,
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H, H-5D), 3.75-3.63 (m, 7 H, H-4A, H-4B, H-5C, H-6abA, H-6abB),
3.62 (s, 3 H, OCH3), 3.61-3.58 (m, 1 H, H-4C), 3.56 (dd, J=10.0,
2.5 Hz, 1 H, H-3A), 3.52-3.48 (m, 2 H, H-2A, H-5B), 1.97, 1.86,
1.80, 1.72 (4 s, 12 H, 4 COCH3), 0.52 (d, J=6.0 Hz, 3 H, CCH3);
13C NMR (CDCl3, 125 MHz): d 170.7, 169.9, 169.5 (4 COCH3),
168.6, 167.8 (PhthCO), 155.1-114.3 (Ar-C), 102.1 (PhCH), 99.5
(C-1C), 98.8 (C-1B), 97.3 (2 C, C-1A, C-1D), 80.6 (C-5A), 80.5 (C-
5C), 76.6 (C-3B), 75.9 (C-3A), 75.4 (C-3C), 75.3 (C-2A), 75.0
(PhCH2), 74.6 (C-5B), 73.8 (C-4B), 73.7 (PhCH2), 73.6 (PhCH2),
72.8 (PhCH2), 71.8 (PhCH2), 71.3 (C-4D), 70.4 (C-4C), 70.2 (C-6B),
69.8 (2 C, C-2D, C-6C), 68.7 (C-6A), 68.4 (C-3D), 68.3 (C-2B), 66.4
(C-4A), 66.2 (C-4D), 56.9 (C-2C), 55.5 (OCH3), 21.1, 20.8, 20.7,
20.6 (COCH3), 16.5 (CCH3); ESI-MS: 1614.6 [M+Na]
+; Anal.
Calcd. for C89H93NO26 (1591.60): C, 67.12; H, 5.89%; found:
66.92; H, 6.12%.
4-Methoxyphenyl (2,3,4-tri-O-benzyl-a-L-
rhamnopyranosyl)-(1R3)-(2-O-acetyl-4,6-O-benzylidene-
a-D-mannopyranosyl)-(1R3)-[2,3,4,6-tetra-O-benzyl-b-D-
mannopyranosyl-(1R4)]-2,6-di-O-benzyl-a-D-
galactopyranoside (18)
To a solution of compound 8 (275.0 mg, 0.77 mmol) and
compound 9 (375.0 mg, 0.78 mmol) in anhydrous CH2Cl2 (5 mL)
was added MS 4 A ˚ (1.0 g) and the reaction mixture was stirred
under argon at room temperature for 30 min. The reaction
mixture was cooled to 230 uC and NIS (190.0 mg, 0.84 mmol)
and TfOH (5 mL) were added to it and the reaction was stirred at
same temperature for 30 min. Thin layer chromatography (TLC;
hexane-EtOAc, 5:1) showed complete disappearance of the
starting materials. To the reaction mixture were added compound
14 (650.0 mg, 0.66 mmol) and NIS (140 mg, 0.62 mmol) and the
stirring reaction mixture was kept at same temperature for another
30 min. The reaction mixture was filtered through a CeliteH bed
and washed with CH2Cl2 (50 mL). The organic layer was
successively washed with 5% Na2S2O3, satd. NaHCO3 and water,
dried (Na2SO4) and concentrated under reduced pressure. The
crude product was purified over SiO2 using hexane-EtOAc (4:1) as
eluant to give pure compound 18 (700.0 mg, 71%). White solid;
m.p. 58–60 uC (EtOH); [a]D
25+16 (c 1.2, CHCl3); IR (KBr): 2934,
1757, 1462, 1384, 1243, 1108, 1078, 757, 699 cm
21;
1H NMR
(CDCl3, 500 MHz): d 7.47-7.07 (m, 50 H, Ar-H), 6.77 (d,
J=9.0 Hz, Ar-H), 5.58 (s, 1 H, PhCH), 5.41 (d, J=3.0 Hz, 1 H,
H-1A), 5.28 (br s, 1 H, H-2C), 5.04 (br s, 1 H, H-1D), 5.02 (br s, 1
H, H-1C), 4.98-4.82 (m, 4 H, PhCH2), 4.71 (d, J=12.0 Hz,
PhCH2), 4.63 (br s, 1 H, H-1B), 4.62-4.46 (m, 11 H, PhCH2), 4.40-
4.34 (m, 4 H, H-3C, H-5C, PhCH2), 4.32-4.28 (m, 3 H, H-4A,H -
3D,H -6 aC), 4.26-4.22 (m, 1 H, H-5A), 4.13 (br s, 1 H, H-2B), 4.10-
4.04 (m, 1 H, H-5D), 3.95-3.83 (m, H-2A, H-3A, H-4B, H-6aB,H -
6bC), 3.82-3.76 (m, 4 H, H-4C, H-6bB, H-6abA), 3.75 (s, 3 H,
OCH3), 3.70-3.66 (m, 1 H, H-3B), 3.63 (br s, 1 H, H-2D), 3.59-
3.50 (m, 2 H, H-4D, H-5B), 2.06 (s, 3 H, COCH3), 1.07 (d,
J=5.8 Hz, 3 H, CCH3);
13C NMR (CDCl3, 125 MHz): d 170.0
(COCH3), 155.3-114.4 (Ar-C), 101.5 (C-1B), 101.1 (PhCH), 97.6
(C-1A), 95.0 (C-1D), 94.0 (C-1C), 83.2 (C-2D), 80.4 (C-4D), 79.5 (C-
4C), 76.5 (C-3D), 75.6 (C-5B), 74.9 (C-2A), 74.7 (C-3A), 74.6 (C-2B),
74.5 (C-3B), 74.4 (PhCH2), 74.3 (2 C, C-4B,P h CH2), 73.4 (PhCH2),
73.0 (PhCH2), 72.9 (2 C, 2 PhCH2), 72.2 (PhCH2), 71.9 (PhCH2),
71.8 (PhCH2), 71.5 (C-4A), 70.5 (C-3C), 70.1 (C-5A), 69.9 (C-6A),
68.8 (C-6B), 68.5 (C-6C), 68.0 (2 C, C-2C, C-5D), 63.9 (C-5C), 55.6
(OCH3); ESI-MS: 1719.7 [M+Na]
+; Anal. Calcd. for C103H108O22
(1696.73): C, 72.86; H, 6.41%; found: 73.04; H, 6.65%.
4-Methoxyphenyl (a-L-rhamnopyranosyl)-(1R3)-(2-
acetamido-2-deoxy-b-D-glucopyranosyl)-(1R3)-[b-D-
mannopyranosyl-(1R4)]-a-D-galactopyranoside (1)
To a solution of compound 16 (700.0 mg, 0.44 mmol) in EtOH
(30 mL) was added hydrazine monohydrate (0.3 mL, 6.18 mmol)
and the reaction mixture was allowed to stir at 80 uC for 6 h. After
removal of the solvents the crude mass was dissolved in acetic
anhydride-pyridine (5 mL; 1:1 v/v) and kept at room temperature
for 1 h. The solvents were removed under reduced pressure to give
the crude acetylated product. To a solution of the crude mass in
CH3OH (15 mL) was added 20% Pd(OH)2-C (200.0 mg) and the
reaction mixture was stirred at room temperature for 24 h. The
reaction mixture was filtered through a CeliteH bed and
evaporated to dryness. A solution of the crude product in 0.1 M
CH3ONa in CH3OH (15 mL) was allowed to stir at room
temperature for 4 h and neutralized with Dowex 50W X8 (H
+)
resin. The reaction mixture was filtered and concentrated to
dryness to give compound 1, which was passed through a
SephadexH LH-20 column using CH3OH-H2O (4:1) as eluant to
give pure compound 1 (200.0 mg, 57%). Glass; [a]D
25+46 (c 1.2,
CH3OH); IR (KBr): 2929, 1763, 1458, 1392, 1257, 1100, 1082,
759, 697 cm
21;
1H NMR (CD3OD, 500 MHz): d 6.85 (d,
J=9.0 Hz, 2 H, Ar-H), 6.77 (d, J=9.0 Hz, 2 H, Ar-H), 5.30 (d,
J=8.5 Hz, 1 H, H-1C), 5.11 (d, J=3.5 Hz, 1 H, H-1A), 4.80 (br s,
1 H, H-1D), 4.46 (br s, 1 H, H-1B), 4.33 (dd, J=8.5 Hz each, 1 H,
H-3C), 4.24 (br s, 1 H, H-2D), 4.06 (dd, J=10.0, 2.5 Hz, H-3D),
3.93 (t, J=8.5 Hz each, 1 H, H-2C), 3.48-3.80 (m, 1 H, H-6aB),
3.78-3.74 (m, 3 H, H-5A, H-5D, H-6bB), 3.66-3.56 (m, 2 H, H-4A,
H-6aA), 3.60 (s, 3 H, OCH3), 3.55-3.51 (m, 4 H, H-2A, H-3B,H -
6ac, H-6bA), 3.49-3.42 (m, 3 H, H-3A, H-5C, H-6bC), 3.40-3.36 (m,
2 H, H-2B, H-4C), 3.25-3.20 (m, 1 H, H-5B), 3.71 (t, J=9.0 Hz
each, 1 H, H-4D), 2.04 (s, 3 H, COCH3), 1.02 (d, J=6.0 Hz, 3 H,
CCH3);
13C NMR (CD3OD, 125 MHz): d 173.0 (COCH3), 154.6-
114.9 (Ar-C), 100.6 (C-1B), 100.2 (C-1D), 99.0 (C-1C), 98.4 (C-1A),
77.9 (C-2C), 77.0 (C-3D), 76.1 (2 C, C-2D, C-5B), 75.6 (C-3A), 73.1
(C-4D), 71.8 (C-4C), 70.9 (C-3B), 70.6 (2 C, C-4A, C-4B), 70.0 (C-
2B), 69.4 (C-5D), 68.8 (C-5C), 67.8 (C-5A), 67.1 (C-2A), 61.1 (C-6B),
60.8 (C-6A), 60.5 (C-6C), 56.4 (C-2C), 55.8 (OCH3), 23.2 (COCH3),
16.4 (CCH3); ESI-MS: 820.3 [M+Na]
+; Anal. Calcd. for
C33H51NO21 (797.30): C, 49.68; H, 6.44%; found: 49.46; H,
6.69%.
4-Methoxyphenyl (a-L-rhamnopyranosyl)-(1R3)-(2-
acetamido-2-deoxy-a-D-glucopyranosyl)-(1R3)-[b-D-
mannopyranosyl-(1R4)]-a-D-galactopyranoside (2)
A solution of compound 18 (650.0 mg, 0.38 mmol) in 0.1 M
CH3ONa in CH3OH (10 mL) was allowed to stir at room
temperature for 1 h and neutralized with Amberlite IR 120 (H
+)
resin. The reaction mixture was filtered and concentrated. To a
solution of the deacetylated product in anhydrous CH2Cl2 (5 mL)
were added pyridine (2 mL) and triflic anhydride (200 mL,
1.19 mmol) and the reaction mixture was stirred at 210uC for
1 h. The solvents were removed under reduced pressure and
triflate derivative was dissolved in HMPT-DMF (6 mL, 2:1 v/v).
To the solution of the triflate derivative was added NaN3
(500.0 mg, 7.69 mmol) and the reaction mixture was allowed to
stir at 90 uC for 8 h. The reaction mixture was diluted with water
and extracted with EtOAc (100 mL). The organic layer was
successively washed with satd. NaHCO3 and water, dried
(Na2SO4) and concentrated to give the crude product, which
was passed through a short pad of SiO2. To a solution of the azido
derivative in CH3OH (15 mL) was added 20% Pd(OH)2-C
(200.0 mg) and the reaction mixture was stirred at room
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CeliteH bed and evaporated to dryness. To a solution of the crude
product in CH3OH (10 mL) was added acetic anhydride (2 mL)
and the reaction mixture was allowed to stir at room temperature
for 1 h. The solvents were removed under reduced pressure to give
compound 2, which was passed through a SephadexH LH-20
column using CH3OH-H2O (4:1) as eluant to give pure compound
2 (155.0 mg, 51%). White powder; [a]D
25+32 (c 1.2, CH3OH); IR
(KBr): 2932, 1757, 1452, 1388, 1233, 1113, 1086, 759, 697 cm
21;
1H NMR (CD3OD, 500 MHz): d 7.10 (d, J=9.0 Hz, 2 H, Ar-H),
6.80 (d, J=9.0 Hz, 2 H, Ar-H), 5.38 (d, J=3.5 Hz, 1 H, H-1A),
5.10 (d, J=1.5 Hz, 1 H, H-1C), 4.90 (d, J=1.5 Hz, 1 H, H-1D),
4.61 (br s, 1 H, H-1B), 4.43 (d, J=2.5 Hz, 1 H, H-2D), 4.20 (dd,
J=10.5, 3.0 Hz, 1 H, H-3A), 4.09 (dd, J=10.0, 3.5 Hz, 1 H, H-
2A), 4.06-4.02 (m, 1 H, H-5A), 4.01-3.99 (m, 2 H, H-3B, H-5D),
3.98-3.95 (m, 1 H, H-3D), 3.94-3.92 (m, 3 H, H-3C, H-4B, H-6aB),
3.91-3.89 (m, 3 H, H-5C, H-6aA, H-6aC), 3.81 (dd, J=9.0, 3.0 Hz,
1 H, H-2C), 3.77-3.74 (m, 2 H, H-4C, H-6bA), 3.73 (s, 3 H, OCH3),
3.65 (dd, J=11.5, 8.0 Hz, 1 H, H-6bC), 3.54 (dd, J=11.0, 6.0 Hz,
1 H, H-6bB), 3.50-3.46 (m, 2 H, H-2B, H-4A), 3.41 (t, J=9.5 Hz
each, 1 H, H-4D), 3.29-3.24 (m, 1 H, H-5B), 1.99 (s, 3 H, COCH3),
1.29 (d, J=6.5 Hz, 3 H, CCH3);
13C NMR (CD3OD, 125 MHz):
d 169.8 (COCH3), 156.7-115.5 (Ar-C), 102.6 (C-1B), 100.7 (C-1A),
99.6 (C-1C), 98.0 (C-1D), 78.2 (C-5B), 77.4 (C-3A), 76.3 (C-3B),
75.1 (C-2B), 74.6 (C-5A), 74.2 (C-4D), 73.9 (C-2D), 72.3 (C-2C),
72.2 (2 C, C-3C, C-5D), 72.1 (C-4B), 70.1 (C-5C), 69.0 (C-4A), 68.8
(C-2A), 68.2 (C-3D), 66.7 (C-4C), 63.2 (C-6B), 62.9 (C-6A), 61.3 (C-
6C), 56.0 (OCH3), 22.4 (COCH3), 18.1 (CCH3); ESI-MS: 820.3
[M+Na]
+; Anal. Calcd. for C33H51NO21 (797.30): C, 49.68; H,
6.44%; found: 49.44; H, 6.70%.
Supporting Information
Scheme S1 Reagents: (a) 0.1 M CH3ONa, CH3OH, room
temperature, 3 h; (b) 2,2-dimethoxypropane, p-TsOH, DMF,
room temperature, 12 h; (c) benzyl bromide, NaOH, DMF, room
temperature, 4 h; (d) 80% aq. AcOH, 80 uC, 1.5 h; (e) Bu2SnO,
MeOH, 70 uC, 3 h; (f) allyl bromide, DMF, TBAB, 60 uC, 8 h,
70% in six steps.
(TIF)
Scheme S2 Reagents: (a) TfOH, CH2Cl2, 225 uC, 1 h, 72%;
(b) 0.1 M CH3ONa, CH3OH, room temperature, 2 h; (c) Dess-
Martin Periodinane, CH2Cl2, room temperature, 1 h; (d) NaBH4,
CH3OH, room temperature, 12 h; (e) acetic anhydride, pyridine,
room temperature, 2 h, 76% in four steps; (f) PdCl2,C H 3OH,
room temperature, 1 h, 76% for 12 and 78% for 14; (g) benzyl
bromide, NaOH, Bu4NBr, THF, room temperature, 3 h, 90%.
(TIF)
Scheme S3 Reagents: (a) N-Iodosuccinimide, TfOH, CH2Cl2,
MS 4 A ˚, 230 uC, 1 h, 77%.
(TIF)
Scheme S4 Reagents: (a) N-Iodosuccinimide, TfOH, CH2Cl2,
MS 4 A ˚, 230 uC, 1 h, 72%; (b) NH2NH2?H2O, EtOH, 80 uC,
6 h; (c) acetic anhydride, pyridine, room temperature, 1 h; (d) H2,
20% Pd(OH)2-C, CH3OH, room temperature, 24 h; (e) 0.1 M
CH3ONa, CH3OH, room temperature, 4 h, 57% in four steps.
(TIF)
Scheme S5 Reagents: (a) a) N-Iodosuccinimide, TfOH, CH2Cl2,
MS 4 A ˚, 230 uC, 30 min, then compound 14 followed by NIS
and TfOH, 230 uC, 30 min, 71%; (b) 0.1 M CH3ONa, CH3OH,
room temperature, 1 h; (c) triflic anhydride, pyridine, CH2Cl2,
210 uC, 1 h; (d) NaN3, HMPT-DMF, 90 uC, 8 h; (e) H2, 20%
Pd(OH)2-C, CH3OH, room temperature, 24 h; (f) acetic anhy-
dride, CH3OH, room temperature, 1 h, 51% in four steps.
(TIF)
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